Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Psychopharmacology (Berl) – November 01, 2024
Source: PubMed Central
Summary
Remarkable findings from initial clinical trials suggested a novel approach for severe PTSD. Researchers explored how MDMA, when combined with specialized psychotherapy, could significantly reduce symptoms. A comprehensive analysis of six early-stage randomized controlled trials revealed positive results, demonstrating substantial improvement in participants' well-being. This innovative treatment strategy provided a strong rationale for advancing to larger-scale clinical trials as an effective PTSD treatment.
Abstract
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.